VWF and von Willebrand disease (hereditary or acquired): The international guidelines for VWD management recommend the use of either hormonal therapy or tranexamic acid in women with VWD and HMB, depending on the woman's reproductive needs.5 Long-term prophylaxis with VWF replacement therapy has been conditionally recommended for patients with VWD who have a history of severe and frequent bleeds.